Louisiana State Employees Retirement System’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
SIMG
NFT
MAP
SOADOR
ETC
EAM
PFSRSONJ
Louisiana State Employees Retirement System's PTGX Position: Q2 2026 in Review
Louisiana State Employees Retirement System increased its Protagonist Therapeutics (PTGX) stake by 1.5% in Q2 2026, buying an estimated $41.8K and bringing the position to 26,500 shares worth $3.25M. The position accounts for 0.05% of the portfolio, ranked #356.
Louisiana State Employees Retirement System first reported a position in PTGX in Q3 2024 and has held it in 8 quarters since. 67 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.
- Louisiana State Employees Retirement System held 26,500 shares of Protagonist Therapeutics worth $3.25M as of Q2 2026.
- Louisiana State Employees Retirement System bought 400 Protagonist Therapeutics shares in Q2 2026, an estimated $41.8K.
- Protagonist Therapeutics made up 0.05% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #356 holding.
- Louisiana State Employees Retirement System first reported a position in Protagonist Therapeutics in Q3 2024 and has held it in 8 quarters since.
- 67 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.
Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.